Dr. Bin Q. Yang, MD
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 11
- In the NPI registry since
- 2015
- Medicare patients seen, 2024
- 281
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2015Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
MA license 295586 -
Advanced Heart Failure and Transplant Cardiology Physician
MA license 295586 -
Internal Medicine Physician
MA license 295586 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Brigham and Women's Hospital Boston, MA
- Massachusetts General Hospital Boston, MA
Medical groups
- Massachusetts General Physicians Organization Inc (3,558 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 281
- Services billed
- 1,361
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 164 | 119 |
| Critical care, first 30-74 minutes | 127 | 35 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 109 | 47 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 99 | 42 |
| Established patient office or other outpatient visit, 40-54 minutes | 93 | 69 |
| Established patient office or other outpatient visit, 30-39 minutes | 56 | 54 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 48 | 28 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 38 | 36 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 17 | 12 |
| New patient office or other outpatient visit, 60-74 minutes | 15 | 15 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Spironolactone Other prescribers in Boston, MA | 105 |
| Metoprolol Succinate Other prescribers in Boston, MA | 97 |
| Entresto (sacubitril/valsartan) Other prescribers in Boston, MA | 93 |
| Jardiance (empagliflozin) Other prescribers in Boston, MA | 51 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Boston, MA | 41 |
| Carvedilol Other prescribers in Boston, MA | 35 |
| Atorvastatin Calcium Other prescribers in Boston, MA | 28 |
| Furosemide Other prescribers in Boston, MA | 20 |
| Losartan Potassium Other prescribers in Boston, MA | 15 |
| Amlodipine Besylate Other prescribers in Boston, MA | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 12 payments worth $4,327 in total to this clinician.
| Edwards Lifesciences Corporation | $4,185 |
|---|---|
| Cvrx, Inc. | $91.89 |
| Abbott Laboratories | $50.00 |
| Consulting Fee | $4,185 |
|---|---|
| Food and Beverage | $142 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Edwards Lifesciences Corporation Dec 10, 2025 | Consulting FeeCompany’s descriptionPayment was made to Baim Institute for Clinical Research | $910 |
| Edwards Lifesciences Corporation Oct 15, 2025 | Consulting FeeCompany’s descriptionPayment was made to Baim Institute for Clinical Research | $650 |
| Edwards Lifesciences Corporation Apr 30, 2025 | Consulting FeeCompany’s descriptionPayment made to Baim Institute For Clinical Research | $650 |
| Edwards Lifesciences Corporation Aug 13, 2025 | Consulting FeeCompany’s descriptionPayment made to Baim Institute For Clinical Research | $390 |
| Edwards Lifesciences Corporation Sep 24, 2025 | Consulting FeeCompany’s descriptionPayment made to Baim Institute For Clinical Research | $390 |
| Edwards Lifesciences Corporation Apr 9, 2025 | Consulting FeeCompany’s descriptionPayment made to Baim Institute For Clinical Research | $350 |
| Edwards Lifesciences Corporation Nov 12, 2025 | Consulting FeeCompany’s descriptionPayment was made to Baim Institute for Clinical Research | $260 |
| Edwards Lifesciences Corporation May 21, 2025 | Consulting FeeCompany’s descriptionPayment made to Baim Institute For Clinical Research | $260 |
| Edwards Lifesciences Corporation Jan 2, 2025 | Consulting FeeCompany’s descriptionPayment made to Baim Institute For Clinical Research | $195 |
| Edwards Lifesciences Corporation Jun 18, 2025 | Consulting FeeCompany’s descriptionPayment made to Baim Institute For Clinical Research | $130 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $1,550 in research payments for these studies, mostly to the institutions running them.
- RESTORE
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.